Fig. 1From: Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerationsThe biomarker development process can be schematically divided into sequential phases, including preanalytical and analytical validation, clinical validation, regulatory approval, and demonstration of clinical utilityBack to article page